VeinGuard

**The safest cervical collar on the market.**

Needs Statement

Current cervical collars are required by 870,000 critical patients per year, yet they cause harm by applying pressure to the jugular vein and causing secondary injury. Our product provides emergency neck stabilization without the risks.

There is a need for a non-compressive cervical collar.

Our Product

A Quick Overview + Demo:

Our Competitors

All of the current leading cervical collars compress the jugular vein -- VeinGuard does not.

Market Strategy

TAM / SAM / SOM

From a broad demand spanning the global emergency medical field right down to our beachhead focused on Orange County, our collar has a strong potential for growth.

Business Model

VeinGuard operates on a multi-channel business model that includes B2B sales to hospitals and emergency services, direct-to-consumer outreach for home care, and licensing partnerships with established medical device manufacturers. This hybrid approach maximizes market penetration while enabling scalable growth.